Clinical Trials ActSection 11
11. Trial licence
(1) No person shall conduct or cause to be conducted
a clinical trial unless –
(a) a sponsor;
Acts 2026 321
(b) the Public Clinical Trial Unit; or
(c) an accredited principal investigator,
holds a trial licence.
(2) No person shall conduct or cause or permit to be
conducted a clinical trial except in accordance with the terms
and conditions of a trial licence.
(3) Where a trial licence is held by an accredited
principal investigator, the accredited principal investigator
shall be responsible for ensuring that the clinical trial is
conducted in accordance with this Act, any regulations made
under it, the conditions of the trial licence and the principles
of Good Clinical Practice.
(4) Every clinical trial shall be conducted under the
supervision of an investigator approved by the Council.
(5) For the purposes of this Act, unless the context
otherwise requires, every reference to a sponsor includes
a trial licence holder who is not a sponsor, and the
obligations imposed on a sponsor, including those under
sections 22, 23, 24, 25, 27 and 28, shall apply accordingly to
that trial licence holder.
(h) in section 12 –
(i) by repealing subsection (1) and replacing it by the
following subsection –
(1) A person eligible to hold a trial licence
under section 11(1) who wishes to obtain a trial licence
shall submit an application concurrently to the Council
and the Ethics Committee through NELS or such other
system as the Council may approve.
(ii) in subsection (3), by deleting the words “The sponsor”
and replacing them by the words “The applicant”;
322 Acts 2026
(iii) by repealing subsection (4) and replacing it by the
following subsection –
(4) On receipt of an application under
subsection (1), the Council and the Ethics Committee
shall review the application concurrently and may
request from the applicant such additional documents
or information as they may consider necessary for the
determination of the application.
(iv) by adding the following new subsections –
(5) Where the Council and the Ethics
Committee require additional documents or
information, they shall, where reasonably practicable,
issue a consolidated request to the applicant.
(6) A request for additional documents or
information shall suspend the applicable review period
until the requested documents or information are
received.
(i) in section 13 –
(i) in subsection (1), in paragraph (f), by deleting the words
“the sponsor and the investigator” and replacing them
by the words “the trial licence holder or the sponsor
and the investigator”;
(ii) in subsection (2), by deleting the word “sponsor” and
replacing it by the word “applicant”;
(iii) by repealing subsection (3) and replacing it by the
following subsection –
(3) On granting an application under
subsection (1), the Council shall issue a trial licence
to –
(a) a sponsor;
(b) the Public Clinical Trial Unit; or
Acts 2026 323
(c) an accredited principal investigator,
on such terms and conditions as it thinks fit and, subject
to section 34A, on payment of such licence fee as may
be prescribed.
(j) by inserting, after section 13, the following new section –